Potbelly Sees Strong Comparable Sales in 1Q, Reiterates ’23 Outlook

Portillo’s First Quarter Revenue Climbs 16% on New Restaurants

Solo Brands Shares Rise on Strong First Quarter Revenue, Guidance Reaffirmation

Eterna Therapeutics Buys Allogeneic Immuno-Oncology Platform from Exacis

First Watch Restaurant Group Shares Climb on New Guidance

Ocean Biomedical Shows More Evidence of Anti-Chi3L1 Antibody Suppressing Cancer

Customized Treatments in Modern Medicine: Hear from Thirty Madison President and CFO Live from the NYSE Floor